Top

BY MD Anderson Staff

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare type of acute leukemia that impacts about 500-1,000 people in the U.S. each year. It mainly affects older patients, but can affect people of any age.

Blastic plasmacytoid dendritic cell neoplasm springs from a rare immune cell that is usually found in the skin, bone marrow, blood, lymph nodes and spleen. Because it affects almost every part of the body and its name...

BPDCN expert Naveen Pemmaraju, M.D.

BY MD Anderson Staff

Certain genetic changes, or mutations, can increase a person’s chances of developing cancer. These changes, known as hereditary cancer syndromes...

BY MD Anderson Staff

When it comes to facing cancer, follicular lymphoma survivor Michael Baker says laughter is the best medicine.

Well, actually lenalidomide...

BY MD Anderson Staff

MD Anderson’s Moon Shots Program™ is designed to reduce the time it takes to move promising cancer discoveries into the clinic, where they can help patients the most. The program focuses resources around 13 cancer types, called Moon Shots™, with the goal of using the knowledge we gain to advance treatment of all types of cancer.

But how do researchers make cancer discoveries? And how do they know which discoveries are the most...

Maggi Morgan, scientific manager of MD Anderson's Cancer Genomics Laboratory

BY MD Anderson Staff

In May 2016, Victor Barreiro learned his melanoma, originally treated in his hometown of Mexico City in 2014, had returned and spread throughout...

BY MD Anderson Staff

Bratton Fennell, 53, is one of the top-ranked distance runners for his age group in the Carolinas. During his brain tumor treatment, it turned...

BY MD Anderson Staff

Growing up in Lebanon, good health came easily to Vartkes Taktajian. Running, soccer and basketball filled many of the natural athlete’s hours...